PT336 – Sisi Li, Ph.D. – Porta Sophia: Psychedelic Prior Art
In this episode, David interviews Sisi Li, Ph.D.: Data Architect for Porta Sophia; a non-profit online library collecting relevant prior art in the world of psychedelics for innovators and patent revi...
12 Jul 20221h 1min
PT335 – Christopher Dawson & Andrew Galloway – Modernizing Traditional Plant Medicine With Neuroscience and Luxury
In this episode, Joe interviews Christopher Dawson & Andrew Galloway: Co-Founders and CEO/COO, respectively, of Dimensions; a company creating retreats blending traditional plant ceremony with modern ...
8 Jul 20221h 9min
PT334 – Prof. David Nutt – The Human Brain, Addiction, and Telling the Truth About Drugs
In this episode, David interviews David Nutt: Psychiatrist, Founder/Chief Scientific Officer at Drug Science, Chief Research Officer at Awakn Life Sciences, and Professor of Neuropsychopharmacology at...
5 Jul 202256min
PT333 – Miriam Volat, MS & T. Cody Swift, MFA – Conservation, Peyote, and Indigenous Biocultural Survival
In this episode, Joe interviews T. Cody Swift, MFT, and Miriam Volat, MS; Co-Directors of The Riverstyx Foundation. They discuss plant medicine bioculture; peyote conservation, and working for the sur...
1 Jul 20221h 16min
PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics
In this episode of the podcast, Joe interviews James Lanthier, the CEO of Mindset Pharma; a biotechnology company discovering and developing new (and hopefully safer, more predictable, and more palata...
28 Jun 20221h 3min
PT331 – Julie Zukof & Dr. Michelle Weiner – Psychedelic Women, Coaching, and Ketamine For Fibromyalgia
In this episode, Joe interviews Julie Zukof: Head of Strategic Partnerships for Nue Life and the creator of Psychedelic Women, and Michelle Weiner: a double board-certified Doctor specializing in inte...
24 Jun 20221h 7min
PT330 – Dick Simon – Researching Ethnobotanical Efficacy and the Search For New Therapeutic Molecules
In this episode, Joe interviews Dick Simon: Co-Founder and CEO of Sensorium Therapeutics, an organization created to research plants we already know are effective and synthesize new ones. How can we b...
21 Jun 20221h 2min
PT329 – Dr. Scott Shannon – The Board of Psychedelic Medicine and Therapies
In this bonus episode, Kyle interviews Dr. Scott Shannon: Co-Founder and CEO of the Board of Psychedelic Medicine and Therapies; a non-profit created to certify healthcare professionals in psychedelic...
21 Jun 202235min
